Tech Nation + BioTech Nation + Global BioEntrepreneurship
Episode 26-40Air Date: October 6, 2026
On this week’s Tech Nation, Moira speaks with Dr Shana Kelley, President of Bioengineering and Head of Biohub Chicago, about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr Harry Selker and Dr Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.
Episode 26-39
Air Date: September 29, 2026
On this week’s Tech Nation, Moira speaks with Pediatric surgeon Dr. Dana Suskind about her book, “Human Raised: Nurturing Connection, Curiosity & Lifelong Learning in the Age of AI”, and navigating the unique challenge AI presents for parents. Then, FUJIFILM Biotechnologies Chairman Toshi Iida joins to share how the company has gone way beyond film into the biotech landscape. And, do you ever feel like a virtual meeting isn’t going quite how you expected? Dr. Andrew Brodsky breaks down the science behind virtual communication.
Episode 26-38
Air Date: September 24, 2026
On this week’s Tech Nation, Moira speaks with Dr. Richard Elwes about his book, “Huge Numbers: A Story of Counting Ambitiously, from 4 ½ to Fish 7”. They discuss what really makes a number “huge,” and how the way we count numbers is intertwined with the way we make sense of the world around us. Then, Founder, President, & CEO Lew Bender shares how Intensity Therapeutics is working to change how chemotherapy is administered to patients, with the hopes of reducing the toll it takes on the body.
BioTech Nation
PODCASTS
October 6, 2026
Toshihisa "Toshi" Iida Chairman, FUJIFILM Biotechnologies
When you think of FUJIFILM, you might be picturing rolls of camera film...but it turns out that's not all they've been working on. FUJIFILM Biotechnologies Chairman Toshi Iida joins to share more about how they're innovating in the world of biotech.
September 29, 2026
Lew Bender,
Founder, President and CEO,
Intensity Therapeutics
- What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.
The J.P. Morgan
Healthcare Conference 2026
5 Companies Ready to
Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma